July 31st 2025
President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Insurers Use Incentives to Guide Cancer Treatment Plans
May 30th 2014Beginning July 1, health providers can expect to receive incentives for prescribing specific cancer treatments backed by the insurance company WellPoint. The WellPoint's innovative program will pay providers $350 per patient per month each time they choose 1 of the insurer's "preferred" cancer treatment options.
Read More
Safety Net Hospitals Already Seeing More Paying Patients And Revenue
May 28th 2014One of the biggest beneficiaries of the health law's expansion of coverage to more than 13 million people this year has been the nation's safety-net hospitals, which treat a disproportionate share of poor and uninsured people and therefore face billions of dollars in unpaid bills.
Read More
Healthcare Utilization and Costs in Persons With Insomnia in a Managed Care Population
Patients with an insomnia diagnosis have higher healthcare utilization and costs than a matched control group, both before and after the diagnosis.
Read More
Effect of Management Strategies and Clinical Status on Costs of Care for Advanced HIV
Antiretroviral drugs have replaced hospitalization and other services as the most costly component of HIV care, except in patients with especially advanced HIV.
Read More
Community-Based Caregiver Support Improves the Costs of Care Associated with Alzheimer's Disease
May 9th 2014As the elderly population grows, state legislators across the United States are seeking to control the rising costs of caring for them. Specifically, legislators are focused on those elderly who have Alzheimer's disease.
Read More
Wayne J. Katon, MD, Discusses How Collaborative Care Drives Quality
May 7th 2014Wayne J. Katon, MD, professor of psychiatry, director of the division of health services and epidemiology, and vice chair of the department of psychiatry and behavioral sciences at the University of Washington Medical School, says that people with psychiatric illness in primary care settings cost the system twice as much as those without mental illness. Comorbidities such as depression can add to those costs.
Watch